Radiopharmaceuticals
•24 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (24)
| Company | Market Cap | Price |
|---|---|---|
|
BMY
Bristol-Myers Squibb Company
RayzeBio introduces radiopharmaceuticals, a direct product/technology category.
|
$93.77B |
$46.11
+1.07%
|
|
CAH
Cardinal Health, Inc.
Nuclear medicine radiopharmaceuticals distribution and related imaging agents.
|
$45.55B |
$190.72
+0.46%
|
|
GEHC
GE HealthCare Technologies Inc.
GE HealthCare markets proprietary radiopharmaceuticals (e.g., Flyrcado) and radiopharmaceutical diagnostics.
|
$34.22B |
$74.98
-0.03%
|
|
BWXT
BWX Technologies, Inc.
Radiopharmaceuticals for nuclear medicine imaging and diagnostics.
|
$19.52B |
$213.47
-0.15%
|
|
OKLO
Oklo Inc.
Atomic Alchemy's production of high-value radioisotopes for medical, industrial, defense, and AI applications aligns with radiopharmaceuticals.
|
$18.48B |
$132.76
-3.37%
|
|
UUUU
Energy Fuels Inc.
Radium/radioisotope recovery plans for targeted alpha therapy isotopes (radiopharmaceuticals).
|
$4.44B |
$20.53
-5.91%
|
|
LNTH
Lantheus Holdings, Inc.
Directly produces radiopharmaceutical imaging agents and related therapies (e.g., PYLARIFY, DEFINITY) and maintains an expanding pipeline in this modality.
|
$3.99B |
$57.70
+3.97%
|
|
ASPI
ASP Isotopes Inc. Common Stock
ASPI’s PET Labs Radiopharmaceuticals production and enriched isotopes are delivered as a core product line.
|
$760.38M |
$10.13
-5.81%
|
|
BCYC
Bicycle Therapeutics plc
Bicycle Radioconjugates (BRC) are radiopharmaceuticals used for targeted cancer therapy/imaging.
|
$559.30M |
$8.05
-8.05%
|
|
MNPR
Monopar Therapeutics Inc.
MNPR-101-Zr and MNPR-101-Ac are radiopharmaceuticals used for imaging and radioligand therapy, respectively.
|
$526.89M |
$88.06
+2.79%
|
|
TOI
The Oncology Institute, Inc.
Radiopharmaceutical therapy is a modality offered in their oncology practice.
|
$397.98M |
$4.46
-2.94%
|
|
YMAB
Y-mAbs Therapeutics, Inc.
Radiopharmaceuticals platform (SADA PRIT) centers on radiopharmaceutical therapeutics.
|
$389.89M |
$8.61
|
|
ACIU
AC Immune S.A.
Radiopharmaceuticals – development of tau and alpha-synuclein PET tracers for diagnostics.
|
$337.46M |
$3.38
|
|
CATX
Perspective Therapeutics, Inc.
Company directly develops and provides radiopharmaceuticals using alpha-emitting Lead-212 for targeted cancer therapy and diagnostic imaging via 203Pb in a theranostic approach.
|
$202.64M |
$2.73
+3.22%
|
|
MOLN
Molecular Partners AG
Radioactive therapeutics are a central modality (Radio-DARPin) enabling radiopharmaceutical approaches.
|
$120.62M |
$3.63
|
|
CSBR
Champions Oncology, Inc.
Radiopharmaceutical services platform launched providing biodistribution and therapy testing.
|
$94.24M |
$6.84
+0.44%
|
|
PSTV
Plus Therapeutics, Inc.
Core product: radiopharmaceutical therapy using Rhenium-186 nanoliposomes for CNS cancers.
|
$53.90M |
$0.53
+0.42%
|
|
FGEN
FibroGen, Inc.
FG-3180 functions as a diagnostic radiopharmaceutical imaging tracer, fitting Radiopharmaceuticals.
|
$44.94M |
$11.12
+0.72%
|
|
ATNM
Actinium Pharmaceuticals, Inc.
Actinium directly develops radiopharmaceutical therapies using alpha-emitting isotopes (Ac-225) for oncology (ATNM-400, Actimab-A, Iomab-ACT).
|
$44.61M |
$1.42
|
|
RDGL
Vivos Inc.
RDGL's core offering is radiopharmaceutical therapy using Y-90 for targeted cancer treatment.
|
$36.05M |
$0.08
|
|
RADX
Radiopharm Theranostics Limited
Core product category: Radiopharmaceuticals used for diagnostic imaging and therapy in oncology.
|
$34.73M |
$5.30
+2.51%
|
|
CLRB
Cellectar Biosciences, Inc.
Core product category: radiopharmaceuticals developed and marketed by Cellectar as radioconjugate therapies.
|
$5.21M |
$3.39
+3.99%
|
|
SHPH
Shuttle Pharmaceuticals Holdings, Inc.
Development of PSMA-targeted theranostics indicates a focus on radiopharmaceuticals for prostate cancer.
|
$1.30M |
$3.00
-1.64%
|
|
INIS
International Isotopes Inc.
Core product: INIS manufactures radiopharmaceutical drugs (I-131) used for diagnostic imaging and therapy.
|
$967348 |
$0.10
|
Loading company comparison...
Loading industry trends...
Loading research report...
